Abu Dhabi has opened applications for its 2026 Healthcare Research and Innovation Fund to support advanced research aligned with the emirate’s long-term health priorities.
The Department of Health – Abu Dhabi, the emirate’s healthcare regulator, in partnership with the Authority of Social Contribution – Ma’an, has announced the opening of applications for the 2026 edition of Abu Dhabi’s Healthcare Research and Innovation Fund. The fund is inviting submissions from researchers, healthcare institutions, and innovators seeking support for projects that advance healthcare innovation.
Also Read: Aster Guardians Global Nursing Award 2026 Extends Deadline as Global Nurse Participation Surges
The 2026 edition is designed to back high-quality research initiatives that contribute to the advancement of precision medicine, enhance early disease detection, and strengthen data-driven clinical decision-making. The programme places a strong emphasis on research that can translate into tangible health outcomes aligned with Abu Dhabi’s evolving healthcare priorities.
Key focus areas include precision medicine and omics-based diagnostics, cell and gene therapies, cancer diagnostics and treatments, metabolic and cardiovascular diseases, neuroinflammatory and neurodegenerative disorders, behavioural and mental health conditions, reproductive endocrinology and infertility, as well as public health and population-based interventions. Proposals will be assessed on scientific quality, feasibility, collaborative impact, and alignment with the emirate’s long-term strategic health objectives.
H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: “As we launch the 2026 cycle of the Healthcare Research and Innovation Fund, we reaffirm Abu Dhabi’s steadfast commitment to enabling innovation and cutting-edge research that deliver measurable and lasting value for our community. Guided by a clear vision for excellence, the Emirate is investing in a collaborative and future-ready scientific environment where innovative ideas can flourish. We look forward to supporting research that advances clinical practice, accelerates the creation of new knowledge and drives better health outcomes for all.”
H.E. Abdullah Humaid Al Ameri, Director General of Authority of Social Contribution – Ma’an, said: “As part of our objectives at Ma’an, we partner with the public, private and civil society in efforts to address social priorities in the emirate of Abu Dhabi across various sectors, including the health sector. Through this programme, we aim to support DoH’s efforts in empowering researchers and innovators who can contribute to enhancing the health and wellbeing of our future generations, in turn generating impact on communities for years to come.”
The application portal is now live on the DoH website. Eligible stakeholders are encouraged to review the published guidelines and timelines before submitting their proposals.
